144 related articles for article (PubMed ID: 37005486)
1. Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420).
Gareth Evans D; McWilliams L; Astley S; Brentnall AR; Cuzick J; Dobrashian R; Duffy SW; Gorman LS; Harkness EF; Harrison F; Harvie M; Jerrison A; Machin M; Maxwell AJ; Howell SJ; Wright SJ; Payne K; Qureshi N; Ruane H; Southworth J; Fox L; Bowers S; Hutchinson G; Thorpe E; Ulph F; Woof V; Howell A; French DP
Br J Cancer; 2023 Jun; 128(11):2063-2071. PubMed ID: 37005486
[TBL] [Abstract][Full Text] [Related]
2. What are the benefits and harms of risk stratified screening as part of the NHS breast screening Programme? Study protocol for a multi-site non-randomised comparison of BC-predict versus usual screening (NCT04359420).
French DP; Astley S; Brentnall AR; Cuzick J; Dobrashian R; Duffy SW; Gorman LS; Harkness EF; Harrison F; Harvie M; Howell A; Jerrison A; Machin M; Maxwell AJ; McWilliams L; Payne K; Qureshi N; Ruane H; Sampson S; Stavrinos P; Thorpe E; Ulph F; van Staa T; Woof V; Evans DG
BMC Cancer; 2020 Jun; 20(1):570. PubMed ID: 32552763
[TBL] [Abstract][Full Text] [Related]
3. Psychological impact of risk-stratified screening as part of the NHS Breast Screening Programme: multi-site non-randomised comparison of BC-Predict versus usual screening (NCT04359420).
French DP; McWilliams L; Bowers S; Woof VG; Harrison F; Ruane H; Hendy A; Evans DG
Br J Cancer; 2023 Apr; 128(8):1548-1558. PubMed ID: 36774447
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants.
Evans DGR; Harkness EF; Brentnall AR; van Veen EM; Astley SM; Byers H; Sampson S; Southworth J; Stavrinos P; Howell SJ; Maxwell AJ; Howell A; Newman WG; Cuzick J
Breast Cancer Res Treat; 2019 Jul; 176(1):141-148. PubMed ID: 30941651
[TBL] [Abstract][Full Text] [Related]
5. Healthcare professionals' views following implementation of risk stratification into a national breast cancer screening programme.
Hawkins R; McWilliams L; Ulph F; Evans DG; French DP
BMC Cancer; 2022 Oct; 22(1):1058. PubMed ID: 36224549
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer risk in young women in the national breast screening programme: implications for applying NICE guidelines for additional screening and chemoprevention.
Evans DG; Brentnall AR; Harvie M; Dawe S; Sergeant JC; Stavrinos P; Astley S; Wilson M; Ainsworth J; Cuzick J; Buchan I; Donnelly LS; Howell A
Cancer Prev Res (Phila); 2014 Oct; 7(10):993-1001. PubMed ID: 25047362
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer risk assessment and risk distribution in 3,491 Slovenian women invited for screening at the age of 50; a population-based cross-sectional study.
Jarm K; Zadnik V; Birk M; Vrhovec M; Hertl K; Klanecek Z; Studen A; Sval C; Krajc M
Radiol Oncol; 2023 Sep; 57(3):337-347. PubMed ID: 37665745
[TBL] [Abstract][Full Text] [Related]
8. Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trial.
Hofvind S; Holen ÅS; Aase HS; Houssami N; Sebuødegård S; Moger TA; Haldorsen IS; Akslen LA
Lancet Oncol; 2019 Jun; 20(6):795-805. PubMed ID: 31078459
[TBL] [Abstract][Full Text] [Related]
9. [Tailored Breast Screening Trial (TBST)].
Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
[TBL] [Abstract][Full Text] [Related]
10. Correction To: Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420).
Gareth Evans D; McWilliams L; Astley S; Brentnall AR; Cuzick J; Dobrashian R; Duffy SW; Gorman LS; Harkness EF; Harrison F; Harvie M; Jerrison A; Machin M; Maxwell AJ; Howell SJ; Wright SJ; Payne K; Qureshi N; Ruane H; Southworth J; Fox L; Bowers S; Hutchinson G; Thorpe E; Ulph F; Woof V; Howell A; French DP
Br J Cancer; 2023 Jun; 128(11):2140. PubMed ID: 37095186
[No Abstract] [Full Text] [Related]
11. Breast cancer risk prediction using Tyrer-Cuzick algorithm with an 18-SNPs polygenic risk score in a European population with below-average breast cancer incidence.
Oblak T; Škerl P; Narang BJ; Blagus R; Krajc M; Novaković S; Žgajnar J
Breast; 2023 Dec; 72():103590. PubMed ID: 37857130
[TBL] [Abstract][Full Text] [Related]
12. Estimating the Cost of 3 Risk Prediction Strategies for Potential Use in the United Kingdom National Breast Screening Program.
Wright SJ; Eden M; Ruane H; Byers H; Evans DG; Harvie M; Howell SJ; Howell A; French D; Payne K
MDM Policy Pract; 2023; 8(1):23814683231171363. PubMed ID: 37152662
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer risk stratification in women of screening age: Incremental effects of adding mammographic density, polygenic risk, and a gene panel.
Evans DGR; van Veen EM; Harkness EF; Brentnall AR; Astley SM; Byers H; Woodward ER; Sampson S; Southworth J; Howell SJ; Maxwell AJ; Newman WG; Cuzick J; Howell A
Genet Med; 2022 Jul; 24(7):1485-1494. PubMed ID: 35426792
[TBL] [Abstract][Full Text] [Related]
14. Inclusion of Endogenous Plasma Dehydroepiandrosterone Sulfate and Mammographic Density in Risk Prediction Models for Breast Cancer.
Gabrielson M; Ubhayasekera KA; Acharya SR; Franko MA; Eriksson M; Bergquist J; Czene K; Hall P
Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):574-581. PubMed ID: 31948996
[TBL] [Abstract][Full Text] [Related]
15. Behavioral and psychological impact of returning breast density results to Latinas: study protocol for a randomized clinical trial.
Patel BK; Ridgeway JL; Ghosh K; Rhodes DJ; Borah B; Jenkins S; Suman VJ; Norman A; Jewett M; Singh D; Vachon CM; Radecki Breitkopf C
Trials; 2019 Dec; 20(1):744. PubMed ID: 31852492
[TBL] [Abstract][Full Text] [Related]
16. Assessing individual breast cancer risk within the U.K. National Health Service Breast Screening Program: a new paradigm for cancer prevention.
Evans DG; Warwick J; Astley SM; Stavrinos P; Sahin S; Ingham S; McBurney H; Eckersley B; Harvie M; Wilson M; Beetles U; Warren R; Hufton A; Sergeant JC; Newman WG; Buchan I; Cuzick J; Howell A
Cancer Prev Res (Phila); 2012 Jul; 5(7):943-51. PubMed ID: 22581816
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer screening knowledge among Hungarian women: a cross-sectional study.
Reményi Kissné D; Gede N; Szakács Z; Kiss I
BMC Womens Health; 2021 Feb; 21(1):69. PubMed ID: 33588813
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer risk feedback to women in the UK NHS breast screening population.
Evans DG; Donnelly LS; Harkness EF; Astley SM; Stavrinos P; Dawe S; Watterson D; Fox L; Sergeant JC; Ingham S; Harvie MN; Wilson M; Beetles U; Buchan I; Brentnall AR; French DP; Cuzick J; Howell A
Br J Cancer; 2016 Apr; 114(9):1045-52. PubMed ID: 27022688
[TBL] [Abstract][Full Text] [Related]
19. An integrated breast cancer risk assessment and management model based on fuzzy cognitive maps.
Subramanian J; Karmegam A; Papageorgiou E; Papandrianos N; Vasukie A
Comput Methods Programs Biomed; 2015 Mar; 118(3):280-97. PubMed ID: 25697987
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
